 only 1.2 mm/y in depth.98 The presence of
symptoms, an associated IMH, and an increase in pleural
effusion appear to be risk factors for complications.83,99
Treatment with TEVAR is indicated for patients who
are symptomatic despite best medical therapy or have
an increase in pleural effusion. The threshold for intervention for asymptomatic patients is also controversial.
According to one study, PAU depth >10 mm and